Study Of Two Non-Myeloablative Stem Cell Transplant Strategies For Low-Grade Lymphoma And CLL
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Robert H. Collins, MD
Simmons Cancer Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
23 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ottawa Regional Cancer Centre
Ottawa, Ontario, Canada
- Princess Margaret Hospital
Toronto, Ontario, Canada
- University of Toronto
Toronto, Ontario, Canada
- Hopital Du Saint-Sacrament, Quebec
Québec, Quebec, Canada
- Rocky Mountain Cancer Centers
Denver, Colorado, United States
- Delaware Clinical & Laboratory Physicians
Newark, Delaware, United States
- Florida Hospital Cancer Institute
Orlando, Florida, United States
- H. Lee Moffitt Cancer Center and Research Institute
Tampa, Florida, United States
- Blood and Marrow Transplant Group of Georgia
Atlanta, Georgia, United States
- Holden Comprehensive Cancer Center
Iowa City, Iowa, United States
- University of Missouri Kansas City School of Medicine
Kansas City, Missouri, United States
- Hackensack University Medical Center
Hackensack, New Jersey, United States
- St. Joseph'S Hospital and Medical Center
Paterson, New Jersey, United States
- James P. Wilmot Cancer Center
Rochester, New York, United States
- Oregon Cancer Institute
Portland, Oregon, United States
- Kimmel Cancer Center of Thomas Jefferson University - Philadelphia
Philadelphia, Pennsylvania, United States
- University of Pennsylvania Cancer Center
Philadelphia, Pennsylvania, United States
- Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, United States
- Simmons Cancer Center - Dallas
Dallas, Texas, United States
- Texas Transplant Institute
San Antonio, Texas, United States
- Massey Cancer Center
Richmond, Virginia, United States
- University of Wisconsin Comprehensive Cancer Center
Madison, Wisconsin, United States
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2001
- Primary completion
- 31 Jan 2003
- Completion
- 31 Jan 2003
- Last update posted
- 10 Apr 2020
- Registered enrollment
- 10
- Registry id
- NCT00041288
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.